Patent details

Basic Information

Publication number:

EP2329849

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP091763920

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder

French Title of Invention:

Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire

German Title of Invention:

Kombination aus einem Alpha-2-Adrenozeptor-Agonisten und einem nichtsteroidalen entzündungshemmenden Mittel zur Behandlung oder Prävention einer Entzündungskrankheit der Haut

SPC Number:

Dates

Filing date:

18/11/2009

Grant date:

29/04/2015

EP Publication Date:

29/04/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/06/2011

EP B1 Publication Date:

29/04/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/11/2015

Expiration date:

18/11/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/11/2009

 

 

Name:

Galderma Research & Development

Address:

Les Templiers 2400 Route des Colles, 06410 Biot, France (FR)

Inventor

1

Name:

Delamadeleine Françoise

Address:

France (FR)

2

Name:

Jomard André

Address:

France (FR)

Classification

Main IPC Class:

A61K 31/196;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages